The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 63, Issue 3-4, 2009, Pages 273-279

  Obaidat, Aiman A ^a   Khanfar, Rasha A ^a   Khawam, Mohammad N ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Cylodextrin; Dissolution; DSC; FT IR; Inclusion complex; Meloxicam; Molecular modeling; X ray diffraction

Indexed keywords

EID: 63049108568     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-008-9517-2     Document Type: Article

References (19)

1. O Bekers EV Uijtendaal JH Beijnen AW Bult JM Underberg 1991 Cyclodextrins in the pharmaceutical field Drug Dev. Ind. Pharm. 17 1503 1549 10.3109/03639049109026630
2. T Loftsson ME Brewster 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1017 1025 10.1021/js950534b
3. P Li SE Tabibi SH Yalkowsky 1998 Combined effect of complexation and pH on solubilization J. Pharm. Sci. 87 1535 1537 10.1021/js9801889
4. KPR Chowdary BN Nalluri 2000 Nimesulide and β-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies Drug Dev. Ind. Pharm. 26 1217 1220 10.1081/DDC-100100995
5. AA Obaidat SM Matalqah NM Najib 2002 Improvement and characterization of the in-vitro dissolution behavior of sulindac by complexation with β-cyclodextrin Acta Pharm. 52 9 18
6. 2 in solution Int. J. Pharm. 106 135 140 10.1016/0378-5173(94)90311-5
7. M Masson T Loftsson S Jonsdottir H Fridriksdottir DS Petersen 1998 Stabilization of ionic drugs through complexation with non-ionic and ionic cyclodextrins Int. J. Pharm. 164 45 55 10.1016/S0378-5173(97)00387-6
8. YL Loukas P Jayasekera G Gregoriadis 1995 Novel liposome-based multicomponent systems for the protection of photolabile agents Int. J. Pharm. 117 85 94 10.1016/0378-5173(94)00320-5
9. RA Rajewski VJ Stella 1996 Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery J. Pharm. Sci. 85 1142 1169 10.1021/js960075u
10. P Luger K Daneck W Engel G Trummlitz K Wagner 1996 Structure and physicochemical properties of meloxicam, a new NSAID Eur. J. Pharm. Sci. 4 175 187 10.1016/0928-0987(95)00046-1
11. S Baboota SP Agarwal 2002 Inclusion complexation of meloxicam with β-cyclodextrin Indian J. Pharm. Sci. 64 408 411
12. S Baboota SP Agarwal 2003 Meloxicam complexation with β-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity Pharmazie 58 73 74
13. N Buchi Naidu KPR Chowadry KVR Murthy V Satyanarayana AR Hayman G Becket 2004 Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems J. Pharm. Biomed. Anal. 35 75 86 10.1016/j.jpba.2004.01.003
14. KPR Chowdary P Raviprakash 2006 Dissolution kinetics of meloxicam-β-cyclodextrin complex system Int. J. Chem. Sci. 4 845 848
15. AA Abdoh MI El-Barghouthi MB Zughul JE Davies AA Badwan 2007 Changes in the conformational structure, microscopic and macroscopic pKas of meloxicam on complexation with natural and modified cyclodextrins Pharmazie 62 55 59
16. Higuchi, T., Connors, K.A.: Phase solubility techniques. In Reilly, C.N. (ed.) Advances in Analytical Chemistry and Instrumentation, vol. 4, pp. 117-212. Interscience, New York (1965)
17. Connors, K.A.: Binding Constants: The Measurement of Molecular Complex Stability, pp. 261-281. Wiley, London (1987)
18. D Duchene C Vaution F Glomot 1986 Cyclodextrins, their value in pharmaceutical technology Drug Dev. Ind. Pharm. 12 2193 2215 10.3109/03639048609042630
19. ME Brewster T Loftsson 2007 Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 645 666 10.1016/j.addr.2007.05.012